MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.

Address

200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428

Founded

2000

Number of Employees

376
Filters

Keyboard Shortcuts: Show (a) | Close (Esc)